Total Payments
$5,230
2021 Payments
$589.69
Companies
28
Transactions
308
Medicare Patients
10,247
Medicare Billing
$639,059
Payment Breakdown by Category
Food & Beverage$5,183 (99.1%)
Education$47.06 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,183 | 303 | 99.1% |
| Education | $47.06 | 5 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $861.85 | 62 | $0 (2021) |
| Amgen Inc. | $585.36 | 46 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $546.48 | 32 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $485.97 | 27 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $395.70 | 17 | $0 (2021) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $302.09 | 25 | $0 (2019) |
| BIOTRONIK INC. | $220.76 | 3 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $212.82 | 15 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $189.80 | 11 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $184.71 | 13 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $589.69 | 31 | Novartis Pharmaceuticals Corporation ($101.03) |
| 2020 | $614.39 | 37 | Janssen Pharmaceuticals, Inc ($171.63) |
| 2019 | $1,175 | 71 | Janssen Pharmaceuticals, Inc ($219.35) |
| 2018 | $1,449 | 78 | Janssen Pharmaceuticals, Inc ($276.68) |
| 2017 | $1,402 | 91 | E.R. Squibb & Sons, L.L.C. ($276.80) |
All Payment Transactions
308 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/09/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/06/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/01/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/10/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: Cardiology | ||||||
| 07/28/2021 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $68.80 | General |
| Category: Diabetes | ||||||
| 07/27/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Diabetes | ||||||
| 07/08/2021 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/01/2021 | Merck Sharp & Dohme Corporation | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/28/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: DIABETES | ||||||
| 05/25/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/24/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/11/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: Cardiovascular | ||||||
| 05/10/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/07/2021 | ARBOR PHARMACEUTICALS, INC. | Edarbyclor (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/27/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: DIABETES | ||||||
| 03/31/2021 | Merck Sharp & Dohme Corporation | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/29/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/23/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/22/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $11.37 | General |
| Category: Cardiovascular | ||||||
| 03/18/2021 | BIOTRONIK INC. | Solia (Device), Edora, BioMonitor | Education | In-kind items and services | $23.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/09/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/08/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/05/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Cardiovascular | ||||||
| 02/22/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,939 | 3,188 | $406,391 | $148,506 |
| 2022 | 23 | 2,615 | 2,798 | $367,657 | $140,374 |
| 2021 | 15 | 757 | 892 | $154,152 | $64,472 |
| 2020 | 31 | 3,936 | 4,770 | $779,679 | $285,707 |
Total Patients
10,247
Total Services
11,648
Medicare Billing
$639,059
Procedure Codes
99
All Medicare Procedures & Services
99 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 638 | 644 | $89,430 | $32,245 | 36.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 334 | 346 | $62,426 | $22,526 | 36.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 142 | 149 | $54,520 | $20,054 | 36.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 119 | 165 | $37,302 | $15,196 | 40.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 148 | 212 | $32,574 | $12,922 | 39.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 180 | 180 | $27,660 | $9,748 | 35.2% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 30 | 30 | $17,617 | $6,479 | 36.8% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 16 | 16 | $11,799 | $4,414 | 37.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 597 | 633 | $11,394 | $3,511 | 30.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 22 | 22 | $7,768 | $3,087 | 39.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 27 | 27 | $7,084 | $2,513 | 35.5% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Facility | 2023 | 117 | 120 | $6,120 | $2,305 | 37.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 19 | 20 | $5,380 | $2,223 | 41.3% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 108 | 115 | $6,697 | $2,215 | 33.1% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 24 | 25 | $8,955 | $2,092 | 23.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 183 | 184 | $6,112 | $1,862 | 30.5% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 17 | 17 | $3,687 | $1,294 | 35.1% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Facility | 2023 | 17 | 17 | $2,763 | $1,064 | 38.5% |
| 93793 | Anticoagulant management of patient taking warfarin | Facility | 2023 | 13 | 74 | $1,722 | $635.45 | 36.9% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Facility | 2023 | 35 | 35 | $1,623 | $618.80 | 38.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 11 | 11 | $1,217 | $563.20 | 46.3% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 57 | 58 | $1,474 | $557.96 | 37.9% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 15 | 15 | $612.00 | $206.10 | 33.7% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 70 | 73 | $455.00 | $173.74 | 38.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 495 | 498 | $74,700 | $26,970 | 36.1% |
About Dr. Michael Gambill, DO
Dr. Michael Gambill, DO is a Internal Medicine healthcare provider based in Williamsburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1679769202.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Gambill, DO has received a total of $5,230 in payments from pharmaceutical and medical device companies, with $589.69 received in 2021. These payments were reported across 308 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($5,183).
As a Medicare-enrolled provider, Gambill has provided services to 10,247 Medicare beneficiaries, totaling 11,648 services with total Medicare billing of $639,059. Data is available for 4 years (2020–2023), covering 99 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Williamsburg, VA
- Active Since 09/18/2007
- Last Updated 08/19/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1679769202
Products in Payments
- XARELTO (Drug) $861.85
- ENTRESTO (Drug) $546.48
- ELIQUIS (Drug) $543.27
- Corlanor (Drug) $422.84
- MULTAQ (Drug) $383.82
- LifeVest (Device) $302.09
- Repatha (Biological) $162.52
- PRADAXA (Drug) $151.85
- BRILINTA (Drug) $146.96
- Vascepa (Drug) $137.91
- Impella (Device) $118.15
- Coronary Orbital Atherectomy System (Device) $117.92
- PRALUENT ALIROCUMAB INJECTION (Biological) $114.53
- CHANTIX (Drug) $87.49
- Ozempic (Drug) $87.29
- Cardiac Monitoring Suite (Device) $80.67
- PRALUENT (Biological) $70.18
- FARXIGA (Drug) $65.86
- (7999) SRC Undivided (Device) $53.69
- Claria MRI (Device) $51.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Williamsburg
Mrs. Frances Jones, M.d, M.D
Internal Medicine — Payments: $17,559
Internal Medicine $17,559
Peter Siersma, Md, MD
Internal Medicine — Payments: $9,529
Internal Medicine $9,529
Dr. Robert Baldwin, M.d, M.D
Internal Medicine — Payments: $7,904
Internal Medicine $7,904
Joselin Tacastacas, Md, MD
Internal Medicine — Payments: $4,556
Internal Medicine $4,556
Krystal Ainsley, Md, MD
Internal Medicine — Payments: $3,492
Internal Medicine $3,492
Johanna Larrazabal, Md, MD
Internal Medicine — Payments: $2,918
Internal Medicine $2,918